AMERICAN INTERNATIONAL GROUP, INC. - ARCUTIS BIOTHERAPEUTICS INC ownership

ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 136 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 4.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of ARCUTIS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$136,255
-42.2%
25,660
+3.7%
0.00%0.0%
Q2 2023$235,848
+7.0%
24,748
+23.5%
0.00%0.0%
Q1 2023$220,352
-24.2%
20,032
+2.0%
0.00%
-50.0%
Q4 2022$290,568
-21.7%
19,633
+1.2%
0.00%
-33.3%
Q3 2022$371,000
+6.3%
19,400
+18.3%
0.00%
+50.0%
Q2 2022$349,000
+32.2%
16,394
+19.4%
0.00%
+100.0%
Q1 2022$264,000
-13.4%
13,733
-6.6%
0.00%
-50.0%
Q4 2021$305,000
-15.7%
14,700
-2.9%
0.00%0.0%
Q3 2021$362,000
-14.4%
15,139
-2.3%
0.00%
+100.0%
Q2 2021$423,000
+8.5%
15,499
+15.1%
0.00%0.0%
Q1 2021$390,000
+15.0%
13,471
+11.9%
0.00%0.0%
Q4 2020$339,000
+6.9%
12,038
+11.4%
0.00%
-50.0%
Q3 2020$317,000
+81.1%
10,810
+86.5%
0.00%
+100.0%
Q2 2020$175,000
-4.9%
5,797
-5.9%
0.00%0.0%
Q1 2020$184,0006,1590.00%
Other shareholders
ARCUTIS BIOTHERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Frazier Life Sciences Management, L.P. 8,684,232$165,956,00012.78%
Bain Capital Life Sciences Investors, LLC 3,000,000$57,330,0006.84%
Pivotal bioVenture Partners Investment Advisor LLC 569,041$10,874,0003.97%
Logos Global Management LP 1,525,000$29,143,0003.58%
1492 Capital Management LLC 178,320$3,408,0002.45%
Cormorant Asset Management, LP 1,000,000$19,110,0001.34%
MPM BioImpact LLC 257,185$4,915,0001.16%
Orbimed Advisors 2,800,000$53,508,0000.99%
SECTORAL ASSET MANAGEMENT INC 220,985$4,223,0000.83%
Rubric Capital Management LP 472,047$9,021,0000.45%
View complete list of ARCUTIS BIOTHERAPEUTICS INC shareholders